The development of new bone substitutes has become an area of great interest in materials science. In fact, hydroxyapatite is the most commonly used biomaterial in defects that require bone reconstruction, and that is certainly why the discovery of new products with its formulation has been increasing continuously. The aim of this study was to analyze the biological behavior of a xenogeneic hydroxyapatite widely disclosed in the literature and a synthetic nano-hydroxyapatite/Beta tricalcium phosphate in critical defects in the calvaria of Wistar rats. For this, the groups were divided as follows: 24 adult male Wistar rats were used, weighing between 300 and 350 g, in three groups with eight animals each. In the CTRL group (control), only the clot was kept, without material insertion; in the Bioss group (bovine hydroxyapatite), Bio Oss®—Gleistlich® was introduced; and in the Blue Bone group (REG), the defect was filled in with synthetic nano-hydroxyapatite associated with betatriphosphate of calcium, Blue Bone®—Regener®. According to the results in Goldner’s Trichromics, we can observe a higher percentage of newly formed bone matrix in the REG group than in the CTRL and Bioss groups; in the VEGF, we had a more adequate cell modulation for blood vessel formation in the Blue Bone group (REG) compared to the Bioss and CTRL groups, while in osteopontin, a higher percentage of bone formation was observed in the Blue Bone group (REG) and Bioss group when compared to the CTRL group. We conclude that bone formation, mitosis-inducing cell modulation and main osteoblast activity were higher in the Blue Bone group (REG) than in the CTRL and Bioss groups.
The nano-hydroxyapatite/β-tricalcium phosphate composite (nano-HA/β-TCP) is widely used in various medical and dental procedures. The absence of in vivo toxicity of nano-HA/β-TCP has been extensively studied, and it is considered one of the most effective synthetic biomaterials for promoting cell differentiation in bone regeneration. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are the primary cell type involved in the osteoinductive process of guided bone regeneration following injury. In the present study, rat BM-MSCs were cultured with nano-HA/β-TCP (80/20%) composite spheroids, and the interaction between the cells and the composite was analyzed using transmission electron microscopy (TEM). Ultrathin sections examined by TEM showed extensive interaction between nano-HA/β-TCP and BM-MSCs. Semi-thin sections stained with toluidine blue revealed the incorporation of the biomaterial into the cell cytoplasm. For the immunohistochemistry analysis, eight adult male Wistar rats weighing approximately 300 g were used in each group. Two bilateral, non-critical-sized 3 mm defects were created in the parietal bones of the calvaria: Control, Bio-Oss®, and Blue Bone® (n = 24) during a 12-week experimental period. Bone formation was evaluated through osteonectin and osteopontin expression. At the ultrastructural level, internalization of the biomaterial and close association with the endoplasmic reticulum (ER) and mitochondria were observed. TEM analysis also revealed no harmful effects on the cells, such as apoptotic or necrotic bodies or cell lysis. These findings indicate that the nano-HA/β-TCP composite demonstrates in vitro biocompatibility and interacts appropriately with BM-MSCs, including incorporation into the cell cytoplasm. In vivo, the Blue Bone® group exhibited superior bone formation when compared with the other groups.